Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Musculoskeletal | Rheumatology
Disease Category: Osteoporosis
Trial Information
Osteoporosis Study for Men.
Osteoporosis in men represents an important, although long
underestimated public health problem. At least 20 percent of cases
of osteoporosis occur in men and may lead to bone fractures and
height loss.
Diablo Clinical Research and Dr. Richard Weinstein are
conducting a research study to compare the effectiveness of 2
treatments: a yearly infusion of zoledronic acid (Zometa®) versus a
weekly oral dose of alendronate (Fosamax®).
You may qualify for the study if you:
- are a male aged 25 - 85
- have been diagnosed with osteoporosis
Qualified participants receive at no cost:
- All investigational medications
- Study-related physical examinations
- Bone density testing & X-rays
- Laboratory tests
To learn more,
Ava Paulazzo, Marketing & Community Outreach
Diablo Clinical Research
2255 Ygnacio Valley Road, Ste. M
Walnut Creek, CA 94598
Phone: 925-930-7267
Fax: 925-930-7392
EMail: apaulazzo@diabloclinical.com
View Google Map
Research Center Information: Diablo Clinical Research
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
